cyclohexanol has been researched along with Day Blindness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peres, MF; Vieira, DS | 1 |
| Domula, M; Felber, W; Gallinat, J; Lang, UE; Schmidt, E; Schulze, D; Stogowski, D; Tugtekin, SM | 1 |
2 other study(ies) available for cyclohexanol and Day Blindness
| Article | Year |
|---|---|
Tension-type headache with aura.
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Bromazepam; Cyclohexanols; Fructose; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Topiramate; Venlafaxine Hydrochloride; Vision Disorders | 2006 |
Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors.
Topics: Aged; Cognition; Cyclohexanols; Eye Diseases; Female; Hallucinations; Humans; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride; Vision Disorders | 2007 |